RUBY® – a tetravalent (2+2) bispecific antibody format with excellent functionality and IgG-like stability, pharmacology and developability properties
Article in mAbs (March 2024)
The most recent citing publications are shown below. View all 82 publications that cite this research output on Dimensions.
Article in mAbs (March 2024)
Article in Nature Reviews Drug Discovery (March 2024)
Article in Medical Oncology (January 2024)